1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsNSW Medical Devices Fund (MDF) – Round 14 is sponsored by NSW Health – Office for Health and Medical Research. This competitive grants program supports the development and commercialisation of innovative medical devices and technologies in NSW, bridging the funding gap between early-stage research and commercial maturity.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Medical Devices Fund | NSW Health The Medical Devices Fund provides grants to drive the commercialisation of highly innovative new devices and technologies in NSW, addressing gaps in the product life cycle between early-stage research and mature investment opportunities.
Grant amount: From $500,000 to $5,000,000 The Medical Devices Fund aims to: Support individuals, companies, public and private hospitals, medical research institutes, universities, other public sector research organisations, and the medical devices industry, to take local innovation to market Increase the uptake of NSW medical devices that are cost effective and contribute to improved patient outcomes.
For Round 14, applicants with projects that address the following NSW Health Research and Innovation Strategy aligned priorities are encouraged to apply: Applicants with projects that do not address the above priorities are also able to apply. Preliminary applications for this grant open: 5 May 2026 Preliminary applications close: 9 June 2026, 5:00pm AEST Full applications for this grant are by invitation only.
Program Guidelines 2026 (PDF 305. 45KB) and other application documents are included below. This program is funded and administered by NSW Health.
All applications will undergo eligibility checks and applications that do not meet all the eligibility criteria will not be considered.
Applicants with a medical device/technology that satisfies the definition of a medical device at the time of submitting the application A financially viable company or commercial enterprise that is headquartered in NSW (or will relocate to NSW during the application process), has an Australian Business Number (ABN), has an annual turnover less than $25 million, and is a legal entity An individual based in NSW who agrees to form such an entity so that the NSW Government can enter into legally binding funding agreements A NSW public research organisation applying through its appropriate technology transfer office, or the CEO or equivalent of the research organisation Applicants who hold the intellectual property or rights to commercialise the medical device/ technology Applicants with projects in the medical device product life cycle from a minimum of Technology Readiness Level 3 Applicants undertaking the majority of project activities in NSW Applicants that can demonstrate why sufficient funding for the entire project cannot be accessed from alternative sources and that the project would not proceed at the proposed scale in NSW without government support.
People who do not meet the eligibility criteria listed above an international company or an Australian subsidiary of an international company a subsidiary of an Australian company (Note: the parent organisation needs to submit the application and will need to satisfy eligibility criteria) Australian Government agencies.
Types of projects funded under this grant The program funds project activities used for any purpose that meets the objectives of the program, subject to the exclusions below.
Examples of activities that can be funded include: device development, including proof-of-concept, prototyping, and piloting studies manufacturing samples for product trials locating other national and international trials and research relevant to the product under development business planning, including conducting market and product assessments intellectual property management The program will not support activities that do not meet the objectives of the program.
Exclusions include but are not limited to acquisition of land and buildings, capital works and general infrastructure costs, any costs directly related to research, PhD stipends, fees for visas, relocation, costs of dependents, insurance, and mobile phones, fees for international students or liabilities for students, donations and gifts, and fine or penalty payments.
ARIA Pre-Production Prototype and Pivotal Trial Approved for Aria Research Pty Ltd $2,000,000 was approved by Minister for Medical Research Date approved February 2025 Location of the recipient Agency funding this grant Acquittal is within 3 months of the Funds being fully expended or at such other time agreed by the Health Administration Corporation Inventia Life Science Pty Ltd Ligo - Robotic Assisted Platform for Renerative Surgery: Pivotal Trial in Skin Cancer Approved for Inventia Life Science Pty Ltd $3,469,000 was approved by Minister for Medical Research Date approved February 2025 Location of the recipient Agency funding this grant Acquittal is within 3 months of the Funds being fully expended or at such other time agreed by the Health Administration Corporation LevTech Lifesciences Pty Ltd FORMUSUS Polymeric Heart Valve Replacement with Lifelong Longevity Approved for LevTech Lifesciences Pty Ltd $2,077,961 was approved by Minister for Medical Research Date approved February 2025 Location of the recipient Agency funding this grant Acquittal is within 3 months of the Funds being fully expended or at such other time agreed by the Health Administration Corporation Cooled Laser Focal Therapy for Prostate Cancer Approved for Medlogical Innovations $2,500,000 was approved by Minister for Health Date approved April 2024 Location of the recipient Agency funding this grant Acquittal is within 3 months of the Funds being fully expended or at such other time agreed by the Health Administration Corporation Value-Added JAZBI™ Bone Implant System Approved for SDIP Innovations Pty Ltd $4,065,000 was approved by Minister for Health Date approved February 2024 Location of the recipient Agency funding this grant Acquittal is within 3 months of the Funds being fully expended or at such other time agreed by the Health Administration Corporation What your application needs to include For full details of what your Preliminary Application needs to include, download: Program Guidelines 2026 (PDF 305.
45KB) Tips for applicants 2026 (PDF 81. 77KB) The Medical Devices Fund has a multi-stage application process. Applicants must submit a Preliminary Application electronically to MOH-OHMRGrants@health.
nsw. gov.au by 5:00 PM AEST 9 June 2026. An information session on the Medical Devices Fund Round 14 will be held during May 2026.
Details on how to register are available on the OHMR | Medical Devices Fund website. The session will provide an overview of the program and the application process, including what a successful application looks like.
NSW Health Medical Devices Fund - Round 14 Information Session What your applications needs to include To apply, you must provide a completed Preliminary Application form and the following attachments: 3-minute pitch video demonstrating the problem the device solves and for which patients, its impact on the health system, the market dynamics, proposed business model, and how the requested funding will assist with commercialisation Completed Business Canvas Model Evidence of technical feasibility Evidence of clinical feasibility Evidence of intellectual property/licensing status Financial statements for FY2024/25 and FY2025/26 Balance Sheet and Profit and Loss statements for FY2025/26.
You must ensure you address all eligibility criteria as specified in the Program Guidelines.
All applications for funding that meet the eligibility criteria will be assessed against the following assessment criteria at both Preliminary and Full Application stage: Impact on health outcomes Economic, social and/or environmental impact for NSW Impact on clinical practice Commercialisation pathway Team expertise and capability More detail about each of the assessment criteria is available in the program guidelines.
The application must be completed in its entirety to be eligible for consideration. Any confidential information should be clearly marked. If your Preliminary Application is shortlisted to proceed, you will be invited to apply for a Full Application.
Applications for this grant opened Tuesday 5 May 2026. Applications must be submitted by 5:00pm AEST Tuesday 9 June 2026. All applications must be submitted electronically to MOH-OHMRGrants@health.
nsw. gov.au . This includes one electronic copy of the application form and attachments and video.
Important: The maximum application file size is 20MB. An acknowledgement of receipt of application will be sent within 3 business days of submission. Applicants should contact the Office if they have not received an acknowledgment after this time on MOH-OHMRGrants@health.
nsw. gov.au Applications cannot be submitted using file-sharing sites, including Google Drive, as they cannot be accessed from the NSW Health system. Please use the file names: ‘Medical Devices Fund 2026_organisation name’ for preliminary applications and ‘Medical Devices Fund2026_organisation name_attachment’ for attachments.
Download and complete application forms here: Preliminary Application 2026 (DOCX 377. 6KB) Business Model Canvas 2026 (DOCX 148. 84KB) After the application is submitted Successful applications will be decided by: The Medical Devices Fund Expert Panel assess each eligible application on a case-by-case basis and put forward recommendations.
NSW Health officials will consider the recommendations before making a final recommendation regarding the funding allocation amount and successful applicants for Ministerial approval. Eligibility check: Following the closing date for applications, the Medical Devices Fund will access relevant technical expertise to determine if each application has satisfied the eligibility criteria.
Review of Preliminary Application: Relevant technical experts will provide initial screening and advice to the Expert Panel regarding the eligibility and quality of the applications against the agreed criteria. The Expert Panel will take this advice into consideration when reviewing the applications and determine which applications will proceed to full application.
Review of Full Application: Submissions of a full application are by invitation only. Following full application assessment, applicants may be required to present the proposal or be interviewed, by invitation only. Funding recommendation: The Expert Panel will agree on the ranking of eligible full applications that proceeded to interview and will put forward a recommendation on the suitability of each proposal for funding to NSW Health.
Decision and notification: NSW Health officials will consider the recommendations before making a final recommendation regarding the funding allocation amount and successful applicants for Ministerial approval, as the designated decision maker. All applicants will be informed as to whether they have been awarded funding. Funding agreements: NSW Health will contact applicants of successful projects to execute a funding agreement.
The funding agreement will specify obligations that relate primarily to the recipient’s accountability for the grant, including using the grant for activities occurring in NSW, the return of unspent grant funds, reporting on the use of the grant and commercialisation progress for the duration of the term, and repayment of grant funds on economic success.
For any enquiries about the Medical Devices Fund, please contact the Office for Health and Medical Research. Email: MOH-OHMRGrants@health. nsw.
gov.au
According to the current listing, eligibility includes: Individuals, companies, hospitals, research institutes, universities, and medical device industry entities headquartered in NSW with an ABN and annual turnover under $25 million. Confirm the full requirements in the official notice before applying.
The current listing shows between $500,000 and $5,000,000 per project. Verify award ceilings, matching requirements, and allowable costs in the official notice.
NSW Medical Devices Fund (MDF) – Round 14 is funded by NSW Health – Office for Health and Medical Research. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
CDMRP's FY26 portfolio funds 34 programs, and October 2026 is dense with full-application deadlines: PRCRP October 5, PCRP October 7, MRP October 14. Every one of them is gated behind a pre-application that closed months earlier. Here is what that two-step structure actually costs applicants, and how to be inside the gate for FY27.
Read articleOn September 4, 2026, HRSA awarded $11.2 million through the Rural Residency Planning and Development program to build 15 new physician residencies across 14 states. Since 2019 the program has invested nearly $77 million, producing 66 accredited programs and 818 approved positions. Here is what the conversion rate reveals, why the specialty mix is narrowing, and how to build a competitive application for the next cycle.
Read articleHRSA-27-017 closes September 29, 2026 and HRSA-27-084 closes November 16, with $20,960,000 and $16,000,000 respectively. The award floors and ceilings are not budget guesses — they are resident headcounts at the $160,000 interim per-resident rate. Read them that way and the eligibility question answers itself.
Read article